Antifibrosis Effect of Novel Oridonin Analog CYD0618 Via Suppression of the NF-κB Pathway
- 1 December 2018
- journal article
- conference paper
- Published by Elsevier in Journal of Surgical Research
- Vol. 232, 283-292
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32DK007639)
This publication has 38 references indexed in Scilit:
- Site-specific Phosphorylation of the p65 Protein Subunit Mediates Selective Gene Expression by Differential NF-κB and RNA Polymerase II Promoter RecruitmentJournal of Biological Chemistry, 2013
- Morphogens and hepatic stellate cell fate regulation in chronic liver diseaseJournal of Gastroenterology and Hepatology, 2012
- BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple TargetsMediators of Inflammation, 2012
- Mechanisms of hepatic fibrogenesisBest Practice & Research Clinical Gastroenterology, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Genomic and in vivo evidence of synergy of a herbal extract compared to its most active ingredient: Rabdosia rubescens vs. oridoninExperimental and Therapeutic Medicine, 2010
- The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammationCardiovascular Research, 2010
- Fibrogenesis in pediatric cholestatic liver disease: Role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment #Hepatology, 2009
- P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cellsActa Pharmacologica Sinica, 2007
- The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosisApoptosis, 2005